Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · IEX Real-Time Price · USD
275.60
-2.61 (-0.94%)
Apr 25, 2024, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,671 | 2,802 | 2,923 | 2,546 | 2,312 | 2,289 | 2,160 | 2,068 | 2,019 | 2,175 | Upgrade
|
| Revenue Growth (YoY) | -4.67% | -4.12% | 14.81% | 10.12% | 0.97% | 5.98% | 4.45% | 2.41% | -7.15% | 1.99% | Upgrade
|
| Cost of Revenue | 1,244 | 1,235 | 1,284 | 1,108 | 1,055 | 1,066 | 972.45 | 929.74 | 897.77 | 996.53 | Upgrade
|
| Gross Profit | 1,427 | 1,567 | 1,638 | 1,438 | 1,257 | 1,223 | 1,188 | 1,138 | 1,122 | 1,179 | Upgrade
|
| Selling, General & Admin | 841.72 | 827.83 | 877.12 | 798.8 | 824.63 | 834.78 | 806.79 | 814.7 | 761.99 | 808.2 | Upgrade
|
| Research & Development | 247.43 | 256.89 | 260.64 | 217.76 | 202.71 | 199.2 | 250.16 | 205.71 | 192.97 | 220.33 | Upgrade
|
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 292.51 | 11.51 | 62.31 | 0 | 0 | Upgrade
|
| Operating Expenses | 1,089 | 1,085 | 1,138 | 1,017 | 1,027 | 1,326 | 1,068 | 1,083 | 954.96 | 1,029 | Upgrade
|
| Operating Income | 337.8 | 482.62 | 500.34 | 421.33 | 229.66 | -103.34 | 119.25 | 55.72 | 166.71 | 149.98 | Upgrade
|
| Interest Expense / Income | 49.44 | 38.11 | 1.55 | 21.86 | 23.42 | 23.96 | 23.01 | 23.38 | 21.69 | 22.13 | Upgrade
|
| Other Expense / Income | 1,138 | 5,149 | -4,950.27 | -4,518.54 | -2,054.84 | -639.96 | -1.57 | -9.22 | -0.83 | -3.7 | Upgrade
|
| Pretax Income | -850.1 | -4,704.27 | 5,449 | 4,918 | 2,261 | 512.66 | 97.81 | 41.56 | 145.85 | 131.56 | Upgrade
|
| Income Tax | -212.78 | -1,076.74 | 1,195 | 1,104 | 502.41 | 147.05 | -24.44 | 15.56 | 36.61 | 42.71 | Upgrade
|
| Net Income | -637.32 | -3,627.54 | 4,254 | 3,814 | 1,759 | 365.61 | 122.25 | 26 | 109.24 | 88.85 | Upgrade
|
| Net Income Growth | - | - | 11.54% | 116.88% | 381.02% | 199.07% | 370.19% | -76.20% | 22.95% | 14.21% | Upgrade
|
| Shares Outstanding (Basic) | 29 | 30 | 30 | 30 | 30 | 30 | 30 | 29 | 29 | 29 | Upgrade
|
| Shares Outstanding (Diluted) | 29 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 29 | 29 | Upgrade
|
| Shares Change | -1.93% | -1.40% | 0.16% | -0.08% | -0.15% | 0.65% | 1.31% | 0.81% | 0.95% | 0.79% | Upgrade
|
| EPS (Basic) | -21.82 | -121.79 | 142.61 | 128.13 | 58.93 | 12.25 | 4.12 | 0.88 | 3.74 | 3.08 | Upgrade
|
| EPS (Diluted) | -21.82 | -121.79 | 140.83 | 126.47 | 58.27 | 12.10 | 4.07 | 0.88 | 3.71 | 3.05 | Upgrade
|
| EPS Growth | - | - | 11.35% | 117.04% | 381.57% | 197.30% | 362.50% | -76.28% | 21.64% | 13.38% | Upgrade
|
| Free Cash Flow | 218.47 | 81.83 | 535.77 | 476.48 | 359.49 | 159.98 | -7.11 | 75.03 | 74.29 | 152.54 | Upgrade
|
| Free Cash Flow Per Share | 7.48 | 2.75 | 17.96 | 16.01 | 12.05 | 5.36 | -0.24 | 2.55 | 2.54 | 5.28 | Upgrade
|
| Gross Margin | 53.42% | 55.93% | 56.05% | 56.48% | 54.38% | 53.43% | 54.98% | 55.05% | 55.54% | 54.18% | Upgrade
|
| Operating Margin | 12.65% | 17.22% | 17.12% | 16.55% | 9.93% | -4.51% | 5.52% | 2.69% | 8.26% | 6.90% | Upgrade
|
| Profit Margin | -23.86% | -129.45% | 145.57% | 149.83% | 76.08% | 15.97% | 5.66% | 1.26% | 5.41% | 4.08% | Upgrade
|
| Free Cash Flow Margin | 8.18% | 2.92% | 18.33% | 18.72% | 15.55% | 6.99% | -0.33% | 3.63% | 3.68% | 7.01% | Upgrade
|
| Effective Tax Rate | - | - | 21.93% | 22.44% | 22.22% | 28.68% | -24.99% | 37.44% | 25.10% | 32.47% | Upgrade
|
| EBITDA | -800.67 | -4,666.16 | 5,451 | 4,940 | 2,284 | 536.62 | 120.82 | 64.94 | 167.54 | 153.69 | Upgrade
|
| EBITDA Margin | -29.97% | -166.51% | 186.50% | 194.05% | 98.82% | 23.44% | 5.59% | 3.14% | 8.30% | 7.07% | Upgrade
|
| EBIT | -800.67 | -4,666.16 | 5,451 | 4,940 | 2,284 | 536.62 | 120.82 | 64.94 | 167.54 | 153.69 | Upgrade
|
| EBIT Margin | -29.97% | -166.51% | 186.50% | 194.05% | 98.82% | 23.44% | 5.59% | 3.14% | 8.30% | 7.07% | Upgrade
|